GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (TSX:BHC) » Definitions » Buildings And Improvements

Bausch Health (TSX:BHC) Buildings And Improvements : C$0 Mil (As of Mar. 2025)


View and export this data going back to 1987. Start your Free Trial

What is Bausch Health Buildings And Improvements?

Bausch Health's quarterly buildings and improvements increased from Sep. 2024 (C$0 Mil) to Dec. 2024 (C$1,164 Mil) but then declined from Dec. 2024 (C$1,164 Mil) to Mar. 2025 (C$0 Mil).

Bausch Health's annual buildings and improvements increased from Dec. 2022 (C$1,084 Mil) to Dec. 2023 (C$1,104 Mil) and increased from Dec. 2023 (C$1,104 Mil) to Dec. 2024 (C$1,164 Mil).


Bausch Health Buildings And Improvements Historical Data

The historical data trend for Bausch Health's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health Buildings And Improvements Chart

Bausch Health Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Buildings And Improvements
Get a 7-Day Free Trial Premium Member Only Premium Member Only 878.70 864.00 1,084.08 1,104.14 1,163.98

Bausch Health Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Buildings And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 1,163.98 -

Bausch Health Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.


Bausch Health Business Description

Traded in Other Exchanges
Address
2150 St Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Executives
Seana Lynne Carson Senior Officer
Joseph Papa Director, Senior Officer
Andrew Charles Von Eschenbach Director
Robert Allen Spurr Senior Officer
Joseph Gordon Senior Officer
Steven Daniel Miller Director
Richard Urbain De Schutter Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Osama Eldessouky Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Amy Wechsler Director
William Douglas Humphries Senior Officer
John Paulson Director
Thomas Ross Sr. Director
Christina Ackermann Senior Officer
Paul Herendeen Senior Officer